Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Mathas, Stephan Dr. (1) (-) Schmitt, Clemens Prof. Dr. (6) Biologie maligner Lymphome (1) (-) Tumorgenetik und zelluläre Stressantworten (6) 2002 (1) 2003 (3) 2004 (2) 2005 (2) 2006 (2) 2007 (4) 2010 (3) 2011 (3) 2012 (3) 2013 (2) 2014 (1) 2016 (8) 2019 (7) 2020 (7) 2021 (11) 2022 (9) (-) 2023 (6) 2024 (3) 6 Ergebnisse: Active Filter: Schmitt, Clemens Prof. Dr.Tumorgenetik und zelluläre Stressantworten2023 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Mai 2023 / Cell Mol Neurobiol Protein biomarkers in blood reflect the interrelationships between stroke outcome, inflammation, coagulation, adhesion, senescence and cancer G. Fuellen U. Walter L. Henze J. Böhmert D. Palmer S. Lee C.A. Schmitt H. Rudolf A. Kowald 06. Mai 2023 / Cell Death Discov N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness Hongliang Dong Lili Zeng Weiwei Chen Qian Zhang Fei Wang Yan Wu Bingjie Cui Jingjing Qi Xin Zhang Cuilan Liu Jiong Deng Y. Yu C.A. Schmitt Jing Du 15. Juni 2023 / J Clin Invest Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors A. Bonifacius B. Lamottke S. Tischer-Zimmermann R. Schultze-Florey L. Goudeva H.G. Heuft L. Arseniev R. Beier G. Beutel G. Cario B. Fröhlich J. Greil L. Hansmann J. Hasenkamp M. Höfs P. Hundsdoerfer E. Jost K. Kafa O. Kriege N. Kröger S. Mathas R. Meisel M. Nathrath M. Putkonen S. Ravens H.C. Reinhardt E. Sala M.G Sauer C. Schmitt R. Schroers N.K. Steckel R.U. Trappe M. Verbeek D. Wolff R. Blasczyk B. Eiz-Vesper B. Maecker-Kolhoff 01. April 2023 / Nat Rev Immunol COVID-19 and cellular senescence C.A. Schmitt T. Tchkonia L.J. Niedernhofer P.D. Robbins J.L. Kirkland S. Lee 01. November 2023 / Am J Hematol Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine - a prospective cohort study by the AGMT L. Pleyer M. Vaisband M. Drost M. Pfeilstöcker R. Stauder S. Heibl H. Sill M. Girschikofsky M. Stampfl-Mattersberger A. Pichler B. Hartmann A. Petzer M. Schreder C.A. Schmitt S. Vallet T. Melchardt A. Zebisch P. Pichler N. Zaborsky S. Machherndl-Spandl D. Wolf F. Keil J. Hasenauer J. Larcher-Senn R. Greil 01. März 2023 / Blood Cells Mol Dis Daratumumab as a novel treatment option in refractory ITP I. Vernava C.A. Schmitt
01. Mai 2023 / Cell Mol Neurobiol Protein biomarkers in blood reflect the interrelationships between stroke outcome, inflammation, coagulation, adhesion, senescence and cancer G. Fuellen U. Walter L. Henze J. Böhmert D. Palmer S. Lee C.A. Schmitt H. Rudolf A. Kowald
06. Mai 2023 / Cell Death Discov N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness Hongliang Dong Lili Zeng Weiwei Chen Qian Zhang Fei Wang Yan Wu Bingjie Cui Jingjing Qi Xin Zhang Cuilan Liu Jiong Deng Y. Yu C.A. Schmitt Jing Du
15. Juni 2023 / J Clin Invest Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors A. Bonifacius B. Lamottke S. Tischer-Zimmermann R. Schultze-Florey L. Goudeva H.G. Heuft L. Arseniev R. Beier G. Beutel G. Cario B. Fröhlich J. Greil L. Hansmann J. Hasenkamp M. Höfs P. Hundsdoerfer E. Jost K. Kafa O. Kriege N. Kröger S. Mathas R. Meisel M. Nathrath M. Putkonen S. Ravens H.C. Reinhardt E. Sala M.G Sauer C. Schmitt R. Schroers N.K. Steckel R.U. Trappe M. Verbeek D. Wolff R. Blasczyk B. Eiz-Vesper B. Maecker-Kolhoff
01. April 2023 / Nat Rev Immunol COVID-19 and cellular senescence C.A. Schmitt T. Tchkonia L.J. Niedernhofer P.D. Robbins J.L. Kirkland S. Lee
01. November 2023 / Am J Hematol Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine - a prospective cohort study by the AGMT L. Pleyer M. Vaisband M. Drost M. Pfeilstöcker R. Stauder S. Heibl H. Sill M. Girschikofsky M. Stampfl-Mattersberger A. Pichler B. Hartmann A. Petzer M. Schreder C.A. Schmitt S. Vallet T. Melchardt A. Zebisch P. Pichler N. Zaborsky S. Machherndl-Spandl D. Wolf F. Keil J. Hasenauer J. Larcher-Senn R. Greil
01. März 2023 / Blood Cells Mol Dis Daratumumab as a novel treatment option in refractory ITP I. Vernava C.A. Schmitt